CHICAGO, IL / ACCESS Newswire / February 5, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a ...

Cosmos Health (COSM) announced the filing of a patent application for treatment for multiple sclerosis, a disabling autoimmune disorder ...

D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...

The exact cause of MS is unknown, but it is thought US, NY, UNITED STATES, January 31, 2025 /EINPresswire / -- Multiple Sclerosis Ms Drugs market industry Overview 2025 By Drug Class (Disease ...

Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.

The drugs’ active ingredient, glatiramer acetate, has been linked to more than 80 cases of anaphylaxis worldwide since ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Potential New Drug Treatment for Multiple Sclerosis Dec. 8, 2023 — Pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis ...

Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...

Novartis on Friday posted adjusted net income well above analyst estimates as sales of established heart failure drug ...